The chemokine receptor CXCR3 is expressed on malignant B cells and mediates chemotaxis

Journal of Clinical Investigation

Volumn 104, Issue 1, 1999, Pages 115-121

  Trentin, Livio ^a   Agostini, Carlo ^a   Facco, Monica ^a   Piazza, Francesco ^a   Perin, Alessandra ^a   Siviero, Marta ^a   Gurrieri, Carmela ^a   Galvan, Silvia ^a   Adami, Fausto ^a   Zambello, Renato ^b   Semenzato, Gianpietro ^a,c  

^a UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

^b Vicenza Hospital   (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR;

ADULT; AGED; ARTICLE; B CELL LEUKEMIA; CELL MIGRATION; CHEMOTAXIS; CONTROLLED STUDY; FEMALE; HAIRY CELL LEUKEMIA; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION;

EID: 0032746176     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI7335     Document Type: Article

References (30)

1. Baggiolini, M., Dewald, B., and Moser, B. 1997. Human chemokines: an update. Annu. Rev. Immunol. 15:675-705.
2. Baggiolini, M. 1998. Chemokines and leukocyte traffic. Nature. 392:565-568.
3. Rollins, B. 1997. Chemokines. Blood. 90:909-928.
4. Farber, J.M. 1997. Mig and IP-10: CXC chemokines that target lymphocytes. J. Leukoc. Biol. 61:246-257.
5. Yoshie, O., Imai, T., and Nomiyama, H. 1997. Novel lymphocyte-specific CC chemokines and their receptors. J. Leukoc. Biol. 62:634-644.
6. Nelson, P.J., and Krensky, A.M. 1998. Chemokines, lymphocytes and viruses: what goes around, comes around. Curr. Opin. Immunol. 10:265-270.
7. Luster, A. 1998. Chemokines: chemotactic cytokines that mediate inflammation. N. Engl. J. Med. 228:436-445.
8. Loetscher, M., et al. 1996. Chemokine receptor specific for IP10 and Mig: structure, function and expression in activated T-lymphocytes. J. Exp. Med. 184:963-969.
9. Qin, S., et al. 1998. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J. Clin. Invest. 101:746-754.
10. Piali, L., et al. 1998. The chemokine receptor CXCR3 mediates rapid and shear-resistant adhesion-induction of effector T lymphocytes by the chemokines IP10 and Mig. Eur. J. Immunol. 28:961-972.
11. Loetscher, M., Loetscher, P., Brass, N., Meese, E., and Moser, B. 1998. Lymphocyte-specific chemokine receptor CXCR3: regulation, chemokine binding and gene localization. Eur. J. Immunol. 28:3696-3705.
12. Sallusto, F., Lenig, D., MacKay, C.R., and Lanzavecchia, A. 1998. Flexible programs of chemokine receptor expression on human polarized helper 1 and 2 lymphocytes. J. Exp. Med. 187:875-883.
13. Cole, K.E., et al. 1998. Interferon-inducible T cell alpha chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective affinity binding to CXCR3. J. Exp. Med. 187:2009-2021.
14. Kim, C.H., and Broxmeyer, H.E. 1999. Chemokines: signal lamps for trafficking of T and B cells for development and effector function. J. Leukoc. Biol. 65:6-15.
15. Harris, N.L., et al. 1994. A revised European-American classification of lymphoid neoplasms: a proposal from the international lymphoma study group. Blood. 84:1361-1392.
16. Rai, K.R., et al. 1975. Clinical staging of chronic lymphocytic leukemia. Blood. 46:219-234.
17. Trentin, L., et al. 1992. Expression and functional role of the p75 interleukin 2 receptor chain on leukemic hairy cells. Cancer Res. 52:5223-5228.
18. Trentin, L., et al. 1990. Mechanisms accounting for the defective natural killer activity in patients with hairy cell leukemia. Blood. 75:1525-1530.
19. Cerutti, A., et al. 1996. The CD5/CD72 receptor system is coexpressed with several functionally relevant counterstructures on human B cells and delivers a critical signaling activity. J. Immunol. 157:1854-1862.
20. Trentin, L., et al. 1997. B lymphocytes from patients with chronic lymphoproliferative disorders are equipped with different costimulatory molecules. Cancer Res. 57:4940-4947.
21. Trentin, L., et al. 1994. Expression and regulation of tumor necrosis factor, interleukin-2, and hematopoietic growth factor receptors in B-cell chronic lymphocytic leukemia. Blood. 84:4249-4256.
22. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260:3440-3450.
23. Di Virgilio, F., Steinberg, T.H., Swanson, J.A., and Silverstein, S.C. 1988. Fura-2 secretion and sequestration in macrophages. A blocker of organic anion transport reveals that these processes occur via a membrane transport system for organic anions. J. Immunol. 140:915-920.
24. Weng, Y.,et al. 1998. Binding and functional properties of recombinant and endogenous CXCR3 chemokine receptors. J. Leukoc. Biol. 273:18288-18291.
25. D'Apuzzo, M., et al. 1997. The chemokine SDF-1, stromal cell-derived factor 1, attracts early stage B cell precursors via the chemokine receptor CXCR4. Eur. J. Immunol. 27:1788-1793.
26. Farace, F., et al. 1994. T cell repertoire in patients with B chronic lymphocytic leukemia. Evidence for multiple in vivo T cell clonal expansions. J. Immunol. 153:3281-3290.
27. Kluin-Nelemans, J.C., et al. 1996. Persistent clonal excess and skewed T-cell repertoire in T cells from patients with hairy cell leukemia. Blood. 87:3795-3802.
28. Rabin, R.L., et al. 1999. Chemokine receptor responses on T cells are achieved through regulation of both receptor expression and signaling. J. Immunol. 162:3840-3850.
29. Murgia, M., et al. 1994. Cytosolic free calcium concentration in the mitogenic stimulation of T lymphocytes by anti-CD3 monoclonal antibodies. Cell Calcium. 16:167-180.
30. Semenzato, G. 1998. Chemotactic cytokines: from the molecular level to the clinical use. Sarcoidosis Vasc. Diffuse Lung Dis. 15:131-133.